Clearstead Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.28M | Buy |
11,960
+9,033
| +309% | +$970K | 0.02% | 387 |
|
|
2025
Q1 | $295K | Buy |
2,927
+620
| +27% | +$62.5K | ﹤0.01% | 715 |
|
|
2024
Q4 | $206K | Sell |
2,307
-54
| -2% | -$4.82K | ﹤0.01% | 844 |
|
|
2024
Q3 | $198K | Buy |
2,361
+67
| +3% | +$5.62K | ﹤0.01% | 863 |
|
|
2024
Q2 | $177K | Buy |
2,294
+444
| +24% | +$34.2K | ﹤0.01% | 852 |
|
|
2024
Q1 | $135K | Sell |
1,850
-16
| -0.9% | -$1.17K | 0.01% | 541 |
|
|
2023
Q4 | $108K | Sell |
1,866
-350
| -16% | -$20.2K | 0.01% | 568 |
|
|
2023
Q3 | $117K | Buy |
2,216
+1,362
| +159% | +$71.9K | ﹤0.01% | 688 |
|
|
2023
Q2 | $46.2K | Hold |
854
| – | – | ﹤0.01% | 739 |
|
|
2023
Q1 | $42.7K | Buy |
854
+195
| +30% | +$9.76K | ﹤0.01% | 698 |
|
|
2022
Q4 | $30.5K | Buy |
+659
| New | +$30.5K | ﹤0.01% | 722 |
|
|
2022
Q2 | – | Sell |
-77
| Closed | -$3K | – | 1289 |
|
|
2022
Q1 | $3K | Buy |
77
+6
| +8% | +$234 | ﹤0.01% | 1137 |
|
|
2021
Q4 | $3K | Hold |
71
| – | – | ﹤0.01% | 1050 |
|
|
2021
Q3 | $3K | Sell |
71
-125
| -64% | -$5.28K | ﹤0.01% | 1071 |
|
|
2021
Q2 | $8K | Buy |
+196
| New | +$8K | ﹤0.01% | 817 |
|